16F10 cells showed larger metastatic possible than B16F1 cells, and
16F10 cells showed higher metastatic potential than B16F1 cells, and remedy with an miR384 inhibitor enhanced the metastatic possible of B16F1 cells (Fig. 12A) and decreased the expression of miR-384…